Link between FDA antidepressant warnings and increased suicide attempts in young people is questionable

Por Olfson, Mark, Schoenbaum, Michael
Publicado no BMJ (2014)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia

Por Marcus, Steven C., Olfson, Mark
Publicado em 2008

Translating Intergenerational Research on Depression Into Clinical Practice

Por Weissman, Myrna M., Olfson, Mark
Publicado em 2009

National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996–2007

Por Comer, Jonathan S., Olfson, Mark, Mojtabai, Ramin
Publicado em 2010

The use of clinical trials in comparative effectiveness research on mental health

Por Blanco, Carlos, Rafful, Claudia, Olfson, Mark
Publicado em 2013

Stimulant Treatment of Young People in the United States

Por Olfson, Mark, King, Marissa, Schoenbaum, Michael
Publicado no J Child Adolesc Psychopharmacol (2016)

National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults

Por Mojtabai, Ramin, Olfson, Mark, Han, Beth
Publicado no Pediatrics (2016)

Prescribing of psychotropic medications to children and adolescents: quo vadis?

Por Correll, Christoph U, Gerhard, Tobias, Olfson, Mark
Publicado em 2013

Assessing and Improving Clinical Insight Among Patients “in Denial”

Por Williams, Arthur Robin, Olfson, Mark, Galanter, Marc
Publicado no JAMA Psychiatry (2015)

Antidepressant Treatment and Health Services Utilization Among HIV-Infected Medicaid Patients Diagnosed with Depression

Por Sambamoorthi, Usha, Walkup, James, Olfson, Mark, Crystal, Stephen
Publicado em 2000

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone

Por Olfson, Mark, Marcus, Steven C., Ascher-Svanum, Haya
Publicado em 2007

Payment Source and Emergency Management of Deliberate Self-Harm

Por Marcus, Steven C., Bridge, Jeffrey A., Olfson, Mark
Publicado em 2012

Psychotropic Medication Treatment of Adolescents: Results from the National Comorbidity Survey–Adolescent Supplement

Por Olfson, Mark, He, Jian-ping, Merikangas, Kathleen Ries
Publicado em 2013

Assault and Mental Disorders: A Cross-Sectional Study of Urban Adult Primary Care Patients

Por Glover, Karinn, Olfson, Mark, Gameroff, Marc J., Neria, Yuval
Publicado em 2010

Delays in Initial Treatment Contact after First Onset of a Mental Disorder

Por Wang, Philip S, Berglund, Patricia A, Olfson, Mark, Kessler, Ronald C
Publicado em 2004

Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges: Expanded use of these medications, frequently off-label, has often outstripped the evidence...

Por Crystal, Stephen, Olfson, Mark, Huang, Cecilia, Pincus, Harold, Gerhard, Tobias
Publicado em 2009

Use of Psychotherapy for Depression in Older Adults

Por Wei, Wenhui, Sambamoorthi, Usha, Olfson, Mark, Walkup, James T., Crystal, Stephen
Publicado em 2005

Influence of Comorbid Mental Disorders on Time to Treatment Seeking for Major Depressive Disorder

Por Olfson, Mark, Liu, Shang-Min, Grant, Bridget F., Blanco, Carlos
Publicado em 2012

MEDNET: A Multi-State Policymaker/Researcher Collaboration to Improve Prescribing Practices

Por Finnerty, Molly, Neese-Todd, Sheree, Bilder, Scott, Olfson, Mark, Crystal, Stephen
Publicado no Psychiatr Serv (2014)

Testing the Drug Substitution Switching-Addictions Hypothesis: A Prospective Study in a Nationally Representative Sample

Por Blanco, Carlos, Okuda, Mayumi, Wang, Shuai, Liu, Shang-Min, Olfson, Mark
Publicado no JAMA Psychiatry (2014)